Boothbay Fund Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-32,324
| Closed | -$185K | – | 2111 |
|
|
2022
Q1 | $185K | Buy |
32,324
+3,864
| +14% | +$22.1K | ﹤0.01% | 1525 |
|
|
2021
Q4 | $260K | Sell |
28,460
-9,368
| -25% | -$85.6K | 0.01% | 1174 |
|
|
2021
Q3 | $404K | Buy |
37,828
+27,510
| +267% | +$294K | 0.01% | 982 |
|
|
2021
Q2 | $160K | Buy |
+10,318
| New | +$160K | 0.01% | 1424 |
|
|
2020
Q2 | – | Sell |
-13,200
| Closed | -$155K | – | 902 |
|
|
2020
Q1 | $155K | Buy |
+13,200
| New | +$155K | 0.01% | 592 |
|
|
2015
Q4 | – | Sell |
-10,854
| Closed | -$265K | – | 573 |
|
|
2015
Q3 | $265K | Buy |
+10,854
| New | +$265K | 0.13% | 212 |
|